Been scrolling through some cheap stocks that actually have analyst backing, and it's interesting how many solid companies trade under $10 without getting mainstream attention. Found a few plays worth digging into if you're hunting for blue chip stocks under $10 with real fundamentals.

The semiconductor space has some gems here. Navitas is doing power chip work for EVs and data centers - gained like 91% this year and analysts are unanimous strong buy on it. Even at these levels it's trading at a 11.66x multiple, which is a discount to most of the sector. Meanwhile, Ambev from Brazil is basically a hidden giant with a $46B market cap but trades dirt cheap. Revenue growth is solid at 15.3% and margins are fat at 18%.

Then there's the international angle - Gerdau controls huge steel operations across the Americas, posting $15.7B revenue last year. Growing like 13% YoY and analysts see 27% upside from current levels. For gaming exposure, Super Group caught some momentum with 15% gains, and the balance sheet is actually stacked with a 13.68 cash-to-debt ratio.

Obviously there's risk here too. Hello Group got hammered by China's lockdowns, down 24% YTD, but if that normalizes you're looking at 49% upside according to the Street. Arhaus in retail is sketchy with real estate headwinds, but growth metrics are insane at 35.6% three-year revenue expansion.

The real kicker? AbCellera's antibody research has analysts calling unanimous strong buy with 311% upside targets. High risk, high reward play if you believe in biotech.

Worth scanning if you want exposure to undervalued names with actual analyst conviction behind them.